Effects of Transendocardial Delivery of Bone Marrow-Derived CD133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL Trial.
about
Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.Cell Therapy for Refractory Angina: A Reappraisal.New Advances in the Management of Refractory Angina PectorisLinking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO)
P2860
Effects of Transendocardial Delivery of Bone Marrow-Derived CD133+ Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effects of Transendocardial De ...... -Controlled REGENT-VSEL Trial.
@en
type
label
Effects of Transendocardial De ...... -Controlled REGENT-VSEL Trial.
@en
prefLabel
Effects of Transendocardial De ...... -Controlled REGENT-VSEL Trial.
@en
P2093
P50
P1433
P1476
Effects of Transendocardial De ...... o-Controlled REGENT-VSEL Trial
@en
P2093
Aleksandra Michalewska-Włudarczyk
Andrzej Ochała
Anna Błach
Beata Ochała
Joanna Ciosek
Michał Tendera
Monika Dzier Zak-Mietła
Sebastian Dworowy
Wacław Kuczmik
Wiesław Cybulski
P304
P356
10.1161/CIRCRESAHA.116.309009
P50
P577
2016-11-30T00:00:00Z